Cynosure Group LLC lowered its position in Booking Holdings Inc. (NASDAQ:BKNG – Free Report) by 44.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 107 shares of the business services provider’s stock after selling 85 shares during the quarter. Cynosure Group LLC’s holdings in Booking were worth $451,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also added to or reduced their stakes in BKNG. Jamison Private Wealth Management Inc. bought a new position in shares of Booking during the third quarter valued at $25,000. Grove Bank & Trust raised its position in Booking by 133.3% during the 2nd quarter. Grove Bank & Trust now owns 7 shares of the business services provider’s stock worth $28,000 after purchasing an additional 4 shares during the last quarter. POM Investment Strategies LLC acquired a new position in Booking during the 2nd quarter worth about $28,000. Kings Path Partners LLC bought a new stake in shares of Booking in the 2nd quarter valued at about $28,000. Finally, West Financial Advisors LLC acquired a new stake in shares of Booking in the third quarter valued at about $29,000. Institutional investors own 92.42% of the company’s stock.
Analyst Upgrades and Downgrades
BKNG has been the topic of a number of recent analyst reports. Wedbush lifted their price objective on Booking from $3,900.00 to $4,750.00 and gave the stock an “outperform” rating in a research note on Friday, October 25th. DA Davidson upped their price objective on shares of Booking from $4,100.00 to $5,005.00 and gave the company a “buy” rating in a research note on Thursday, October 31st. BMO Capital Markets lifted their target price on shares of Booking from $4,205.00 to $5,155.00 and gave the stock an “outperform” rating in a research note on Thursday, October 31st. Benchmark reaffirmed a “buy” rating and set a $4,600.00 price target on shares of Booking in a research report on Tuesday, October 29th. Finally, Bank of America lifted their price objective on Booking from $4,448.00 to $4,850.00 and gave the stock a “neutral” rating in a research report on Thursday, October 31st. Ten equities research analysts have rated the stock with a hold rating, twenty-three have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $4,820.50.
Booking Price Performance
Shares of BKNG stock opened at $5,223.15 on Thursday. The firm has a 50-day moving average of $4,552.59 and a 200-day moving average of $4,071.32. Booking Holdings Inc. has a one year low of $3,079.50 and a one year high of $5,237.00. The company has a market cap of $172.89 billion, a P/E ratio of 35.44, a P/E/G ratio of 1.59 and a beta of 1.38.
Booking Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 31st. Shareholders of record on Friday, December 6th will be paid a $8.75 dividend. The ex-dividend date is Friday, December 6th. This represents a $35.00 annualized dividend and a yield of 0.67%. Booking’s dividend payout ratio (DPR) is 23.75%.
About Booking
Booking Holdings Inc, formerly The Priceline Group Inc, is a provider of travel and restaurant online reservation and related services. The Company, through its online travel companies (OTCs), connects consumers wishing to make travel reservations with providers of travel services across the world. It offers consumers an array of accommodation reservations (including hotels, bed and breakfasts, hostels, apartments, vacation rentals and other properties) through its Booking.com, priceline.com and agoda.com brands.
Read More
- Five stocks we like better than Booking
- Stock Market Sectors: What Are They and How Many Are There?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- The 3 Best Retail Stocks to Shop for in August
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What Are Dividends? Buy the Best Dividend Stocks
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Booking Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Booking and related companies with MarketBeat.com's FREE daily email newsletter.